other material
confidence high
sentiment negative
materiality 0.75
VolitionRx prices $16.5M public offering of 13M shares at $1.27 per share
VOLITIONRX LTD
- Gross proceeds of $16.5M from 13M shares at $1.27/share; net proceeds ~$15.4M.
- Underwriters granted 30-day option to buy up to 1.95M additional shares at same price.
- Net proceeds for R&D, clinical studies, commercialization, working capital, and possible M&A.
- Underwriter warrants issued to buy up to 448,500 shares at $2.00/share, exercisable after 6 months.
- Offering expected to close on June 5, 2023, subject to customary conditions.